Email Updates
Go to Basic Search
Results
Total Results: 34 records
Showing results for "reduced".
-
cds.ahrq.gov/sites/default/files/cds/artifact/136331/Benzodiazepine%20Patient%20Handout.pdfJanuary 01, 2018 - Microsoft PowerPoint - Updated Handouts - Read-Only REDUCING MEDICATIONS SAFELY TO MEET LIFE’S CHANGES FOCUS ON BENZODIAZEPINE RECEPTOR AGONISTS (BZRAs)FOCUS ON BENZODIAZEPINE RECEPTOR AGONISTS & Z-DRUGS (BZRAs) As life changes, your medication needs may change as well. Medications that were once good for you, …
-
CDS Connect Work Group June 2021 Summary (pdf file)
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Summary_0.pdfJanuary 01, 2021 - CDS Connect Work Group June 2021 Summary CDS (Clinical Decision Support) Connect Work Group Meeting Summary June 17, 2021 3:00-4:00 pm ET Attendees: 41 people, including 3 phone dial-ins Organization Attendee Names AHRQ Sponsors Edwin Lomotan; Mario Teran; Roland Gamache; Steve Bernstein (4) Work Group… -
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdfJanuary 01, 2024 - People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced … People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced
-
June 2021 CDS Connect Work Group Slides (pdf file)
cds.ahrq.gov/sites/default/files/workgroups/13461/CDS_Connect_WG_June_2021_Slides_0.pdfJanuary 01, 2021 - June 2021 CDS Connect Work Group Slides June 2021 CDS Connect Work Group Call Meeting Agenda Schedule Topic 3:00 - 3:02 • Roll Call, Michelle Lenox (MITRE) 3:02 - 3:05 • Review of the Agenda, Maria Michaels (CDC) 3:05 - 3:50 • Using CDS to Reduce Harm From Drug-Drug Interactions: Case Study of Warfarin and N… -
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdfJanuary 01, 2023 - People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced … People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced
-
CDS Connect Pilot Final Report (doc file)
cds.ahrq.gov/sites/default/files/cds/artifact/18/Pilot%20Report_Final_0.docxMarch 01, 2018 - Integration Testing 24 Pilot Findings and Lessons Learned 25 Pilot Outcomes 25 Focus Group Findings 25 Reduced … Reduced Clinician Burden When asked if the pilot CDS reduced clinician burden, clinicians said that it -
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdfJanuary 01, 2024 - People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced … People with chronic kidney disease are at higher risk of side effects from lipid medications due to reduced
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2022.pdfJanuary 01, 2022 - Task Management (Manage Project Resources; Section 2) With reduced tasking in Year 6 the CDS Connect … This resulted in a reduced focus on immediate CDS Connect priorities and, instead, a broader focus in
-
Warfarin-Nsaids Mdia Implementation Guide (doc file)
cds.ahrq.gov/sites/default/files/cds/artifact/1141/Warfarin-NSAIDs%20MDIA%20Implementation%20Guide.docxNovember 11, 2019 - Implementation Guide Warfarin - NSAIDs Prepared by: Eric Chou Under funding from AHRQ grants R21 HS023826 and R01 HS025984 MDIA publication No. 001 November 11, 2019 Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do not necessarily represen… -
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdfJanuary 01, 2020 - allowed simplifying the code of the CDS Authoring Tool in some areas, improved overall performance, reduced … The team also reduced the length of the meeting from 90 to 60 minutes, shared the draft slide deck in
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdfSeptember 01, 2018 - Reduced Provider Burden The clinicians were asked about their usual process for reviewing patient information … Pilot Findings and Lessons Learned Pilot Objectives Focus Group Findings Usefulness and Usability Reduced
-
2024 Intervention Content Statin Patient 1 (xls file)
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_Intervention_Content_Statin_Patient_1.xlsxJanuary 01, 2024 - Example Intervention Text Example Patient-Facing Intervention Text: Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention General Information The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Statin Use for the Primary Preven… -
CDS Connect: Final Report 2023 (pdf file)
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2023.pdfJanuary 01, 2023 - CDS Connect: Final Report 2023 CDS Connect: Final Report 2023 CDS Connect Clinical Decision Support (CDS) Connect is a freely available, web-based platform that enables … -
cds.ahrq.gov/taxonomy/term/8871August 23, 2024 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/1066/2024_CDS_Connect_IG_Diabetes_Part_Two_Counseling_1.pdfJanuary 01, 2024 - Implementation Guide: Prediabetes and Type 2 Diabetes: Part Two, Counseling Implementation Guide Prediabetes and Type 2 Diabetes: Part Two, Counseling Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Mode…
-
Apr-2017-Cholesterol-Wg-Notes (doc file)
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docxJanuary 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 04/19/2017 Time 01:00 – 3:00 PM EST AGENDA · Welcome · Brief Overview of Existing CDS Connect Artifacts · Clarify Logic Details for USPTF-related Artifacts · Discuss Best Approach for Transforming eCQM Specifications into CDS Logic · Next Steps an… -
CAMH Long Doc Template (pdf file)
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdfJune 07, 2019 - Enhanced consistency across implementation sites • Enhanced precision in guideline implementation • Reduced … redundancy at implementation level • Reduced translation time from bench to bedside This CDS artifact -
cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdfJanuary 01, 2015 - risk of substantial harm) to the health or safety of himself or others that cannot be eliminated or reduced … is a significant risk of substantial harm to the individual or others that cannot be eliminated or reduced
-
cds.ahrq.gov/sites/default/files/cds/artifact/1146/Warfarin-Antidepressants%20MDIA%20Implementation%20Guide.docxAugust 29, 2020 - Implementation Guide Warfarin - Antidepressants Prepared by: MDIA contact information Under funding from AHRQ grants R21 HS023826 and R01 HS025984 MDIA publication No. 002 August 29, 2020 Disclaimer The findings and conclusions in this document are those of the author(s), who are responsible for its content, and do no…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_CDS_Connect_IG_Diabetes_Part_One_Screening_0.pdfJanuary 01, 2024 - Implementation Guide: Prediabetes and Type 2 Diabetes: Part One, Screening Implementation Guide Prediabetes and Type 2 Diabetes: Part One, Screening Agency for Healthcare Research and Quality 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 75FCMC18D0047 Prepared by: CMS Alliance to Moder…
SHARE:
Search the AHRQ Archive
Information and reports more than 5 years old may be found in the AHRQ Archive site.
Search Within A Specific AHRQ Site
You selected to view results for the following site:
